Our Therapeutic Centers of Excellence
Veristat has supported over 390 Oncology projects across a multitude of solid tumor and hematologic malignancy indications.
Veristat is proud to have worked on more than 300 rare disease projects across a diverse range of indications.
Veristat has conducted more than 160 Infectious Disease projects for products that prevent or combat viral, bacterial, fungal or parasitic infections.
Veristat has partnered with clients to advance countless products through clinical development for Neurology and CNS disorders that have no cure or limited treatment options available today.
Veristat has supported breakthrough therapies that treat and manage cardiovascular disease, the leading killer of people today.